Key Takeaways
- Rocket Lab announces Q1 2026 financial results after trading ends on May 7
- Options market implies a 13.88% price swing for RKLB stock post-earnings
- Analysts forecast revenue around $190.9 million, representing 50%+ annual growth
- Expected loss per share of $0.04–$0.07, narrowing from -$0.12 year-over-year
- Analyst consensus price target ranges from $83.31–$89.00 with “Moderate Buy” rating
Rocket Lab is scheduled to release its Q1 2026 financial results following market close on Thursday, May 7, at 5:00 PM ET. Trading near $77 per share, RKLB stock commands a market capitalization of approximately $43.9 billion.
The options market is forecasting a 13.88% price movement in either direction after the announcement. This projected volatility significantly exceeds Rocket Lab’s four-quarter average post-earnings move of 4.65%.
Analyst consensus points to quarterly revenue near $190.99 million, marking more than 50% growth compared to the same period last year. Earnings per share are projected to show a loss between $0.04 and $0.07, representing meaningful improvement from the $0.12-per-share loss recorded in Q1 2025.
Beyond the financial metrics, investor attention will center heavily on developments surrounding the Neutron rocket initiative.
Neutron represents a 43-meter partially reusable launch vehicle engineered for satellite deployment and cargo transport missions. The rocket is targeted for its maiden flight in late 2026 or early 2027. If Neutron achieves operational success, Rocket Lab could emerge as a viable competitor to SpaceX’s Falcon 9 platform.
Profitability Metrics and Contract Pipeline Under Scrutiny
Profitability indicators will receive intense scrutiny. Rocket Lab’s GAAP gross margin reached 34.4% in 2025, though sustained margin expansion remains essential for achieving overall profitability.
The company concluded Q4 2025 with an all-time high backlog valued at $1.85 billion. Market participants will be looking for evidence that this contract pipeline is translating into accelerating revenue performance.
Management Stock Sales and Institutional Investment Trends
Regarding insider transactions, CEO Peter Beck divested 18,857 shares on March 2 at a price of $69.59 per share. On the identical date, CFO Adam Spice sold 62,744 shares valued at approximately $4.37 million.
Cumulatively, company insiders have offloaded $16.49 million in stock during the previous 90 days. Corporate insiders currently maintain an 8.40% ownership stake in the company.
Institutional investors have demonstrated contrasting behavior. Alliancebernstein expanded its holdings by 818.8% during Q3. Amundi increased its position by 308.4% in the corresponding timeframe.
State Street, Deutsche Bank, and Renaissance Technologies have similarly augmented their stakes. Institutional ownership now represents 71.78% of RKLB stock.
On the analyst front, Needham reduced its price objective from $110 to $95 while maintaining a Buy recommendation. Wells Fargo launched coverage with an Equal Weight stance and a $60 price target. Roth MKM elevated its target from $90 to $100 with a Buy rating.
Cantor Fitzgerald reaffirmed an Overweight rating with an $85 price objective. The mean price target among analysts stands at $83.31, spanning a range from approximately $60 to $100.
RKLB maintains a consensus “Moderate Buy” recommendation from 17 analysts — comprising two Strong Buys, nine Buys, five Holds, and one Sell.
The stock has fluctuated between $20.23 and $99.58 over the trailing 12-month period. Its 50-day moving average currently stands at $72.14, while the 200-day moving average is positioned at $68.10.



